Neuritis óptica bilateral y COVID-19: caso clínico

Authors

  • Eden Belmont-Wasserlauf Servicio de Oftalmología, HIGA General San Martín, La Plata, Argentina
  • Agustín Ignacio Fernández Servicio de Oftalmología, HIGA General San Martín, La Plata, Argentina
  • Mariana Jurado Servicio de Oftalmología, HIGA General San Martín, La Plata, Argentina
  • Gabriela Armas Servicio de Oftalmología, HIGA General San Martín, La Plata, Argentina
  • Jesica Florero Servicio de Oftalmología, HIGA General San Martín, La Plata, Argentina

DOI:

https://doi.org/10.70313/2718.7446.v15.n2.154

Keywords:

optic neuritis, bilateral papillitis, COVID-19, SARS-CoV2, vaccine

Abstract

Objective: To present a case report of a patient with bilateral optic neuritis, seropositive for SARS-CoV2.
Case report: A 36-year-old male patient who suffered from COVID-19 presented frontal lobe headache accompanied by pain with eye movements and blurring of vision (first in his left eye and then in his right eye), following the first dose of the AstraZeneca/Oxford vaccine against COVID-19, 22 days prior to the symptom onset. 
Initially, the visual acuity test result was 8/10 in both eyes without any correction and showed no improvement whatsoever with the pinhole occluder. The fundus examination showed bilateral papillitis. The optical coherence tomography showed findings for bilateral optic disc elevation. Therefore, the patient was treated with endovenous corticosteroids, having a good evolution. 
Conclusion: Bilateral optic neuritis can be related to the disease produced by the SARS-CoV2 virus, as was presented in this case. 

Published

2022-06-21

How to Cite

[1]
Belmont-Wasserlauf, E., Fernández, A.I., Jurado, M., Armas, G. and Florero, J. 2022. Neuritis óptica bilateral y COVID-19: caso clínico. Oftalmología Clínica y Experimental. 15, 2 (Jun. 2022). DOI:https://doi.org/10.70313/2718.7446.v15.n2.154.

Issue

Section

Casos Clínicos

Most read articles by the same author(s)